Shopping Cart 0
Cart Subtotal
AED 0

Prosthetic Heart Valve Market by Type (Transcather, Tissue and Mechanical): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 15410

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 23117

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 30824
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

The prosthetic heart valve market report covers forecast and analysis on a global and regional level. The study provides historic data 2015 along with a forecast from 2016 to 2021 based revenue (USD Million). The study comprises of drivers and restraints for the market along with their impacts on demand over the forecast period. In addition, the prosthetic heart valve market report provides detail study of opportunities existing in prosthetic heart valve market on a global level. The competitive scenario and product portfolio of the key manufacturers are included in the report, in order to provide the users of this report with the comprehensive view of the prosthetic heart valve market. The competitive landscape in the prosthetic heart valve market is well explained with an analysis of Porters five forces model, strategic development, and patent analysis. The study cover in market attractiveness analysis, in which type segments are benchmarked based on their market size, growth rate, and attractiveness. There are mainly three types of the prosthetic heart valve that are transcatheter valves, tissue valve, and the mechanical valve. All the segments have been analyzed based on current and future trends and the market is estimated from 2015 to 2021. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India, and Brazil. The report provides the comprehensive competitive view with company profiles of the key players operating in the global market. Key players profiled in the report include Colibri Heart Valve, LLC, Cytograft Tissue Engineering, Inc. (CTE), Direct Flow Medical, Inc., Edwards Lifesciences LLC, Heart Leaflet Technologies (HLT), Perouse Medical, St. Jude Medical Inc., and Sorin Group. This report segments the prosthetic heart valve market as follows: Prosthetic Heart Valve Market: Type Segment Analysis Transcatheter valve Tissue valve Mechanical valve Prosthetic Heart Valve Market: Regional Segment Analysis North America U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa

READ MORE

Table Of Content

Scope

Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global market revenue, 2015-2021(USD Million) 2.2. Global prosthetic heart valve market: Snapshot Chapter 3. Prosthetic Heart Valve Market Global and Industry Analysis 3.1. Prosthetic heart valve: Market dynamics 3.2. Market drivers 3.2.1. Drivers of global prosthetic heart valve market: Impact analysis 3.2.2. Increasing prevalence of heart disorders 3.3. Market restraints 3.3.1. Restraints of global prosthetic heart valve market: Impact analysis 3.3.2. High cost of the therapy 3.4. Opportunities 3.4.1. Increasing demand from the emerging economies 3.4.2. Introduction of new techniques 3.5. Porters five forces analysis 3.6. Market Attractiveness Analysis 3.6.1. Market attractiveness analysis by type segment 3.6.2. Market attractiveness analysis by regional segment Chapter 4. Global Prosthetic Heart Valve Market-Competitive Landscape 4.1. Company market share, 2014 4.1.1. Global prosthetic heart valve market : company market share, 2015 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Product Launch 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures 4.2.4. Research and Development, Product and Regional Expansion 4.3. Product Portfolio 4.4. Patent Analysis (2011-2016) 4.4.1. Patent Trend 4.4.2. Patent Share by company 4.4.3. By Region Chapter 5. Global Prosthetic Heart Valve Market Type Segment Analysis 5.1. Global prosthetic heart valve market: type overview 5.1.1. Global prosthetic heart valve market revenue share, by type, 2015-2021 5.2. Transcather valve 5.2.1. Global prosthetic heart valve market, by transcather valve, 2015-2021(USD Million) 5.3. Tissue valve 5.3.1. Global prosthetic heart valve market, by tissue valve, 2015-2021(USD Million) 5.4. Mechanical valve 5.4.1. Global prosthetic heart valve market, by mechanical valve, 2015-2021(USD Million) Chapter 6. Global Prosthetic Heart Valve market Regional Segment Analysis 6.1. Global prosthetic heart valve market: Regional overview 6.1.1. Global prosthetic heart valve market revenue share by region, 2015-2021 6.2. North America 6.2.1. North America prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.2.2. U.S. 6.2.2.1. U.S. prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.3. Europe 6.3.1. Europe prosthetic heart valve market revenue, by a type, 2015-2021(USD Million) 6.3.2. Germany 6.3.2.1. Germany prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.3.3. France 6.3.3.1. France prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.3.4. UK 6.3.4.1. UK prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.4. Asia Pacific 6.4.1. Asia Pacific prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.4.2. China 6.4.2.1. China prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.4.3. Japan 6.4.3.1. Japan prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.4.4. India 6.4.4.1. India prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.5. Latin America 6.5.1. Latin America prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.5.2. Brazil 6.5.2.1. Brazil prosthetic heart valve market revenue, by type, 2015-2021(USD Million) 6.6. Middle East and Africa 6.6.1. Middle East and Africa prosthetic heart valve market revenue, by type, 2015-2021(USD Million) Chapter 7. Company Profile 7.1. Colibri Heart Valve, LLC 7.1.1. Overview 7.1.2. Financials 7.1.3. Product portfolio 7.1.4. Business strategy 7.1.5. Recent developments 7.2. Cytograft Tissue Engineering, Inc. (CTE) 7.2.1. Overview 7.2.2. Financials 7.2.3. Product portfolio 7.2.4. Business strategy 7.2.5. Recent developments 7.3. Direct Flow Medical, Inc. 7.3.1. Overview 7.3.2. Financials 7.3.3. Product portfolio 7.3.4. Business strategy 7.3.5. Recent developments 7.4. Edwards Lifesciences LLC 7.4.1. Overview 7.4.2. Financials 7.4.3. Product portfolio 7.4.4. Business strategy 7.4.5. Recent developments 7.5. Heart Leaflet Technologies (HLT) 7.5.1. Overview 7.5.2. Financials 7.5.3. Product portfolio 7.5.4. Business strategy 7.5.5. Recent developments 7.6. Perouse Medical 7.6.1. Overview 7.6.2. Financials 7.6.3. Product portfolio 7.6.4. Business strategy 7.6.5. Recent developments 7.7. St. Jude Medical Inc. 7.7.1. Overview 7.7.2. Financials 7.7.3. Product portfolio 7.7.4. Business strategy 7.7.5. Recent developments 7.8. Sorin Group 7.8.1. Overview 7.8.2. Financials 7.8.3. Product portfolio 7.8.4. Business strategy 7.8.5. Recent developments 7.9. Symetis 7.9.1. Overview 7.9.2. Financials 7.9.3. Product portfolio 7.9.4. Business strategy 7.9.5. Recent developments 7.10. Transcatheter Technologies Gmbh 7.10.1. Overview 7.10.2. Financials 7.10.3. Product portfolio 7.10.4. Business strategy 7.10.5. Recent developments 7.11. On-X Life Technologies, Inc. 7.11.1. Overview 7.11.2. Financials 7.11.3. Product portfolio 7.11.4. Business strategy 7.11.5. Recent developments 7.12. Neovasc Inc. 7.12.1. Overview 7.12.2. Financials 7.12.3. Product portfolio 7.12.4. Business strategy 7.12.5. Recent developments 7.13. Micro Interventional Devices, Inc 7.13.1. Overview 7.13.2. Financials 7.13.3. Product portfolio 7.13.4. Business strategy 7.13.5. Recent developments 7.14. Leman Cardiovascular 7.14.1. Overview 7.14.2. Financials 7.14.3. Product portfolio 7.14.4. Business strategy 7.14.5. Recent developments 7.15. JenaValve Technology 7.15.1. Overview 7.15.2. Financials 7.15.3. Product portfolio 7.15.4. Business strategy 7.15.5. Recent developments 7.16. Boston Scientific Corporation 7.16.1. Overview 7.16.2. Financials 7.16.3. Product portfolio 7.16.4. Business strategy 7.16.5. Recent developments 7.17. Claret Medical, Inc. 7.17.1. Overview 7.17.2. Financials 7.17.3. Product portfolio 7.17.4. Business strategy 7.17.5. Recent developments 7.18. Medtronic, Inc. 7.18.1. Overview 7.18.2. Financials 7.18.3. Product portfolio 7.18.4. Business strategy 7.18.5. Recent developments 7.19. TTK Healthcare 7.19.1. Overview 7.19.2. Financials 7.19.3. Product portfolio 7.19.4. Business strategy 7.19.5. Recent developments 7.20. Braile Biomdica 7.20.1. Overview 7.20.2. Financials 7.20.3. Product portfolio 7.20.4. Business strategy 7.20.5. Recent developments Chapter 8. Patents 8.1. U.S. (US Patents) 8.2. Europe (EP documents) 8.3. Japan (Abstracts of Japan) 8.4. Global (WIPO (PCT))

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com